drugset / Trial / NCT00671541

Nasospore Stent For Use in Enodscopic Sinus Surgery

NCT00671541

Phase 4 Withdrawn Lahey Clinic
Non-randomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate a stenting material called Nasopore. This is a synthetic material approved by FDA for use as a stent in postoperative sinus surgery patients. This study will compare the Nasopore stent to other approved stenting materials.

Timeline

Start
2006-03
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Bacitracin Unknown 100000 iu
Subject Gentamicin Small molecule 80 mg